ECMO在儿童心脏移植中的应用

蔡子文; 张泰隆; 王寅; 董念国

doi:10.3969/j.issn.1674-7445.2023.01.006

ECMO在儿童心脏移植中的应用

doi: 10.3969/j.issn.1674-7445.2023.01.006

430022 武汉，华中科技大学同济医学院附属协和医院心脏大血管外科

基金项目:

湖北省重点研发项目 2020BCA061

详细信息

作者简介:

通讯作者:
王寅, Email: wangyin0817@hotmail.com

董念国, Email: dongnianguo@hotmail.com

中图分类号: R617, R541
计量
- 文章访问数: 384
- HTML全文浏览量: 103
- PDF下载量: 86
- 被引次数: 0
出版历程
- 收稿日期: 2022-07-23
- 网络出版日期: 2023-01-17
- 刊出日期: 2023-01-15

Application of ECMO in pediatric heart transplantation

Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

More Information

Corresponding author: Wang Yin, Email: wangyin0817@hotmail.com; Dong Nianguo, Email: dongnianguo@hotmail.com

摘要

摘要: 体外膜肺氧合（ECMO）可将人体内静脉血液引流至体外，在人工环境下完成红细胞氧合后再重新输入人体，在心肺功能严重不全患者中替心肺完成气体交换及全身血液灌注，在心脏移植领域也发挥着重要的作用。除心脏移植术后循环支持治疗之外，对于术前存在呼吸循环衰竭的患者也可使用ECMO延长心脏移植的等待时间，并与心脏移植手术桥接。然而，目前ECMO在儿童心脏移植中的应用，仍存在围手术期病死率较高、治疗时机难以选择等关键问题。本文就ECMO在儿童心脏移植中应用的发展历史，儿童心脏移植术前、术后ECMO的使用情况，儿童使用ECMO相关并发症，心室辅助装置（VAD）在儿童心脏移植中的应用现状进行简要综述，以期为促进ECMO在儿童心脏移植中的应用提供参考。
- 心脏移植 /
- 儿童 /
- 体外膜肺氧合（ECMO） /
- 心室辅助装置（VAD） /
- 循环衰竭 /
- 桥接治疗 /
- 支持治疗 /
- 原发性移植物功能障碍
Abstract: Extracorporeal membrane oxygenation (ECMO) could pump the blood from human veins to the outside of the body, oxygenate the red blood cells in an artificial environment and then return them back into the body. ECMO could replace the heart and lungs to complete gas exchange and systemic blood perfusion in patients with severe cardiopulmonary insufficiency, which also plays an important role in the field of heart transplantation. Besides circulatory support treatment after heart transplantation, ECMO may also be used to prolong the waiting time for heart transplantation in patients with respiratory and circulatory failure before operation, as a bridging therapy for heart transplantation. However, at present, the application of ECMO in pediatric heart transplantation still exist challenges, such as high perioperative mortality and difficulty in determining the timing of treatment, etc. In this article, the development history of ECMO application in pediatric heart transplantation, use of ECMO before and after pediatric heart transplantation, ECMO-related complications in children, and application of ventricular assist device (VAD) in pediatric heart transplantation were briefly reviewed, aiming to provide reference for promoting the application of ECMO in pediatric heart transplantation.
- Heart transplantation /
- Children /
- Extracorporeal membrane oxygenation (ECMO) /
- Ventricular assist device (VAD) /
- Circulatory failure /
- Bridging therapy /
- Support treatment /
- Primary graft dysfunction

HTML全文

下载: 全尺寸图片幻灯片

参考文献(48)

[1]	HADAYA J, BENHARASH P. Extracorporeal membrane oxygenation[J]. JAMA, 2020, 323(24): 2536. DOI: 10.1001/jama.2020.9148.
[2]	BAFFES T, PATEL K, JEGATHESAN S. Total cardiopulmonary bypass with the Lande-Edwards membrane oxygenator[J]. Am J Cardiol, 1972, 29(5): 672-677. DOI: 10.1016/0002-9149(72)90169-5.
[3]	HILL JD, O'BRIEN TG, MURRAY JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). use of the Bramson membrane lung[J]. N Engl J Med, 1972, 286(12): 629-634. DOI: 10.1056/NEJM197203232861204.
[4]	BARTLETT RH, GAZZANIGA AB, FONG SW, et al. Prolonged extracorporeal cardiopulmonary support in man[J]. J Thorac Cardiovasc Surg, 1974, 68(6): 918-932.
[5]	BARTLETT RH. Esperanza: the first neonatal ECMO patient[J]. ASAIO J, 2017, 63(6): 832-843. DOI: 10.1097/MAT.0000000000000697.
[6]	QUINTEL M, BARTLETT RH, GROCOTT MPW, et al. Extracorporeal membrane oxygenation for respiratory failure[J]. Anesthesiology, 2020, 132(5): 1257-1276. DOI: 10.1097/ALN.0000000000003221.
[7]	PENNINGTON DG, SWARTZ MT. Circulatory support in infants and children[J]. Ann Thorac Surg, 1993, 55(1): 233-237. DOI: 10.1016/0003-4975(93)90529-q.
[8]	WEINER L, MAZZEFFI MA, HINES EQ, et al. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry[J]. Clin Toxicol (Phila), 2020, 58(7): 705-710. DOI: 10.1080/15563650.2019.1676896.
[9]	MARATTA C, POTERA RM, VAN LEEUWEN G, et al. Extracorporeal Life Support Organization (ELSO): 2020 pediatric respiratory ELSO guideline[J]. ASAIO J, 2020, 66(9): 975-979. DOI: 10.1097/MAT.0000000000001223.
[10]	DESHPANDE S, SPARKS JD, ALSOUFI B. Pediatric heart transplantation: year in review 2020[J]. J Thorac Cardiovasc Surg, 2021, 162(2): 418-421. DOI: 10.1016/j.jtcvs.2021.04.073.
[11]	GODOWN J, SMITH AH, THURM C, et al. Mechanical circulatory support costs in children bridged to heart transplantation - analysis of a linked database[J]. Am Heart J, 2018, 201: 77-85. DOI: 10.1016/j.ahj.2018.04.006.
[12]	BROWN G, MOYNIHAN KM, DEATRICK KB, et al. Extracorporeal Life Support Organization (ELSO): guidelines for pediatric cardiac failure[J]. ASAIO J, 2021, 67(5): 463-475. DOI: 10.1097/MAT.0000000000001431.
[13]	DEL NIDO PJ, ARMITAGE JM, FRICKER FJ, et al. Extracorporeal membrane oxygenation support as a bridge to pediatric heart transplantation[J]. Circulation, 1994, 90(5 Pt 2): Ⅱ66-Ⅱ69.
[14]	FISER WP, YETMAN AT, GUNSELMAN RJ, et al. Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation[J]. J Heart Lung Transplant, 2003, 22(7): 770-777. DOI: 10.1016/s1053-2498(02)00808-2.
[15]	ALMOND CS, SINGH TP, GAUVREAU K, et al. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry[J]. Circulation, 2011, 123(25): 2975-2984. DOI: 10.1161/CIRCULATIONAHA.110.991505.
[16]	EDELSON JB, HUANG Y, GRIFFIS H, et al. The influence of mechanical circulatory support on post-transplant outcomes in pediatric patients: a multicenter study from the International Society for Heart and Lung Transplantation (ISHLT) Registry[J]. J Heart Lung Transplant, 2021, 40(11): 1443-1453. DOI: 10.1016/j.healun.2021.06.003.
[17]	HANNAN MM, XIE R, COWGER J, et al. Epidemiology of infection in mechanical circulatory support: a global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry[J]. J Heart Lung Transplant, 2019, 38(4): 364-373. DOI: 10.1016/j.healun.2019.01.007.
[18]	孙永丰, 张菁, 王国华, 等. 儿童心脏移植单中心回顾分析[J/CD]. 实用器官移植电子杂志, 2021, 9(4): 273-280. DOI: 10.3969/j.issn.2095-5332.2021.04.005. SUN YF, ZHANG J, WANG GH, et al. Single center retrospective analysis of pediatric heart transplantation[J/CD]. Pract J Organ Transplant (Electr Vers), 2021, 9(4): 273-280. DOI: 10.3969/j.issn.2095-5332.2021.04.005.
[19]	SINGH TP, MEHRA MR, GAUVREAU K. Long-term survival after heart transplantation at centers stratified by short-term performance[J]. Circ Heart Fail, 2019, 12(11): e005914. DOI: 10.1161/CIRCHEARTFAILURE.118.005914.
[20]	KOBASHIGAWA J, ZUCKERMANN A, MACDONALD P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation[J]. J Heart Lung Transplant, 2014, 33(4): 327-340. DOI: 10.1016/j.healun.2014.02.027.
[21]	NAIR AG, SLEEPER LA, SMOOT LB, et al. Extracorporeal membrane oxygenation support after heart transplantation in children-outcomes of a single center cohort[J]. Pediatr Crit Care Med, 2020, 21(4): 332-339. DOI: 10.1097/PCC.0000000000002192.
[22]	PROFITA EL, GAUVREAU K, RYCUS P, et al. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients[J]. J Heart Lung Transplant, 2019, 38(6): 601-608. DOI: 10.1016/j.healun.2019.01.1310.
[23]	AVTAAR SINGH SS, BANNER NR, RUSHTON S, et al. ISHLT primary graft dysfunction incidence, risk factors, and outcome: a UK national study[J]. Transplantation, 2019, 103(2): 336-343. DOI: 10.1097/TP.0000000000002220.
[24]	SABATINO M, VITALE G, MANFREDINI V, et al. Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: epidemiology, risk factors, and outcomes[J]. J Heart Lung Transplant, 2017, 36(11): 1217-1225. DOI: 10.1016/j.healun.2017.02.014.
[25]	GONG TA, JOSEPH SM, LIMA B, et al. Donor predicted heart mass as predictor of primary graft dysfunction[J]. J Heart Lung Transplant, 2018, 37(7): 826-835. DOI: 10.1016/j.healun.2018.03.009.
[26]	TRUBY LK, DEROO S, SPELLMAN J, et al. Management of primary graft failure after heart transplantation: preoperative risks, perioperative events, and postoperative decisions[J]. Clin Transplant, 2019, 33(6): e13557. DOI: 10.1111/ctr.13557.
[27]	D'ALESSANDRO C, AUBERT S, GOLMARD JL, et al. Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation[J]. Eur J Cardiothorac Surg, 2010, 37(2): 343-349. DOI: 10.1016/j.ejcts.2009.05.034.
[28]	MARASCO SF, ESMORE DS, NEGRI J, et al. Early institution of mechanical support improves outcomes in primary cardiac allograft failure[J]. J Heart Lung Transplant, 2005, 24(12): 2037-2042. DOI: 10.1016/j.healun.2005.06.007.
[29]	李飞, 王怡轩, 孙永丰, 等. 儿童心脏移植单中心临床分析[J/CD]. 中华移植杂志(电子版), 2020, 14(3): 172-176. DOI: 10.3877/cma.j.issn.1674-3903.2020.03.009. LI F, WANG YX, SUN YF, et al. A single-center experience of pediatric heart transplantation[J/CD]. Chin J Transplant (Electr Edit), 2020, 14(3): 172-176. DOI: 10.3877/cma.j.issn.1674-3903.2020.03.009.
[30]	BADULAK J, ANTONINI MV, STEAD CM, et al. Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the Extracorporeal Life Support Organization[J]. ASAIO J, 2021, 67(5): 485-495. DOI: 10.1097/MAT.0000000000001422.
[31]	CHATURVEDI RR, MACRAE D, BROWN KL, et al. Cardiac ECMO for biventricular hearts after paediatric open heart surgery[J]. Heart, 2004, 90(5): 545-551. DOI: 10.1136/hrt.2002.003509.
[32]	DALTON HJ, REEDER R, GARCIA-FILION P, et al. Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation[J]. Am J Respir Crit Care Med, 2017, 196(6): 762-771. DOI: 10.1164/rccm.201609-1945OC.
[33]	CAPRAROLA SD, NG DK, CARROLL MK, et al. Pediatric ECMO: unfavorable outcomes are associated with inflammation and endothelial activation[J]. Pediatr Res, 2022, 92(2): 549-556. DOI: 10.1038/s41390-021-01817-8.
[34]	POPUGAEV KA, BAKHAREV SA, KISELEV KV, et al. Clinical and pathophysiologic aspects of ECMO-associated hemorrhagic complications[J]. PLoS One, 2020, 15(10): e0240117. DOI: 10.1371/journal.pone.0240117.
[35]	THOMAS J, KOSTOUSOV V, TERUYA J. Bleeding and Thrombotic complications in the use of extracorporeal membrane oxygenation[J]. Semin Thromb Hemost, 2018, 44(1): 20-29. DOI: 10.1055/s-0037-1606179.
[36]	FLETCHER K, CHAPMAN R, KEENE S. An overview of medical ECMO for neonates[J]. Semin Perinatol, 2018, 42(2): 68-79. DOI: 10.1053/j.semperi.2017.12.002.
[37]	BARBARO RP, PADEN ML, GUNER YS, et al. Pediatric Extracorporeal Life Support Organization registry international report 2016[J]. ASAIO J, 2017, 63(4): 456-463. DOI: 10.1097/MAT.0000000000000603.
[38]	CHIARINI G, CHO SM, WHITMAN G, et al. Brain injury in extracorporeal membrane oxygenation: a multidisciplinary approach[J]. Semin Neurol, 2021, 41(4): 422-436. DOI: 10.1055/s-0041-1726284.
[39]	SAID AS, GUILLIAMS KP, BEMBEA MM. Neurological monitoring and complications of pediatric extracorporeal membrane oxygenation support[J]. Pediatr Neurol, 2020, 108: 31-39. DOI: 10.1016/j.pediatrneurol.2020.03.014.
[40]	DIPCHAND AI, KIRK R, NAFTEL DC, et al. Ventricular assist device support as a bridge to transplantation in pediatric patients[J]. J Am Coll Cardiol, 2018, 72(4): 402-415. DOI: 10.1016/j.jacc.2018.04.072.
[41]	YARLAGADDA VV, MAEDA K, ZHANG Y, et al. Temporary circulatory support in U.S. children awaiting heart transplantation[J]. J Am Coll Cardiol, 2017, 70(18): 2250-2260. DOI: 10.1016/j.jacc.2017.08.072.
[42]	MOONSAMY P, AXTELL AL, IBRAHIM NE, et al. Survival after heart transplantation in patients bridged with mechanical circulatory support[J]. J Am Coll Cardiol, 2020, 75(23): 2892-2905. DOI: 10.1016/j.jacc.2020.04.037.
[43]	JEEWA A, IMAMURA M, CANTER C, et al. Long-term outcomes after transplantation after support with a pulsatile pediatric ventricular assist device[J]. J Heart Lung Transplant, 2019, 38(4): 449-455. DOI: 10.1016/j.healun.2018.10.005.
[44]	BARGE-CABALLERO G, CASTEL-LAVILLA MA, ALMENAR-BONET L, et al. Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: results from a nationwide Spanish registry[J]. Interact Cardiovasc Thorac Surg, 2019, 29(5): 670-677. DOI: 10.1093/icvts/ivz155.
[45]	RICARTE BRATTI JP, CAVAYAS YA, NOLY PE, et al. Modalities of left ventricle decompression during VA-ECMO therapy[J]. Membranes (Basel), 2021, 11(3): 209. DOI: 10.3390/membranes11030209.
[46]	PUERTO E, TAVAZZI G, GAMBARO A, et al. Interaction between VA-ECMO and the right ventricle[J]. Hellenic J Cardiol, 2022, 68: 17-24. DOI: 10.1016/j.hjc.2022.07.003.
[47]	NAIR AG, SLEEPER LA, SMOOT LB, 等. 儿童心脏移植后的体外膜肺氧合支持: 单中心队列研究[J]. 中国小儿急救医学, 2021, 28(2): 151. DOI: 10.3760/cma.j.issn.1673-4912.2021.02.103. NAIR AG, SLEEPER LA, SMOOT LB, et al. Extracorporeal membrane oxygenation support after heart transplantation in children-outcomes of a single center cohort[J]. Chin Pediatr Emerg Med, 2021, 28(2): 151. DOI: 10.3760/cma.j.issn.1673-4912.2021.02.103.
[48]	王风, 孔艳霞, 杨青. 体外膜肺氧合辅助下暴发性心肌炎患儿心脏移植一例[J]. 中华儿科杂志, 2020, 58(10): 843-844. DOI: 10.3760/cma.j.cn112140-20200310-00210. WANG F, KONG YX, YANG Q. Pediatric heart transplantation for a case with fulminant myocarditis aided by extracorporeal membrane oxygenation[J]. Chin J Pediatr, 2020, 58(10): 843-844. DOI: 10.3760/cma.j.cn112140-20200310-00210.